Literature DB >> 9409387

Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.

G Blake1, S Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9409387     DOI： 10.1212/wnl.49.6.1747-a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

2.  Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.

Authors:  G Bigliardi; J Mandrioli; F Valzania; P Nichelli; N Casula; A M Simone; P Sola
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

Review 3.  Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Authors:  A Bayas; P Rieckmann
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

4.  Myasthenia gravis development and crisis subsequent to multiple sclerosis.

Authors:  Kurosh Gharagozli; Maziar Shojaei; Ali Amini Harandi; Nayyereh Akbari; Manouchehr Ilkhani
Journal:  Case Rep Med       Date:  2011-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.